{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:12:30Z","timestamp":1790946750492,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010096","name":"Secretar\u00eda de Educaci\u00f3n P\u00fablica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.dld.2024.05.010","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T23:23:55Z","timestamp":1717197835000},"page":"1887-1896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of key markers for the stages of nonalcoholic fatty liver disease: An integrated bioinformatics analysis and experimental validation"],"prefix":"10.1016","volume":"56","author":[{"given":"Itayetzi","family":"Reyes-Avenda\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3940-5617","authenticated-orcid":false,"given":"Ana Beatriz","family":"Villase\u00f1or-Altamirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9077-2159","authenticated-orcid":false,"given":"Edilburga","family":"Reyes-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Velazquez-Enriquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Balti\u00e9rrez-Hoyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5972-8547","authenticated-orcid":false,"given":"Carolina","family":"Pi\u00f1a-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Muriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8292-8157","authenticated-orcid":false,"given":"Saul","family":"Villa-Trevi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7363-4870","authenticated-orcid":false,"given":"Jaime","family":"Arellanes-Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4861-8235","authenticated-orcid":false,"given":"Ver\u00f3nica Roc\u00edo","family":"V\u00e1squez-Garz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.dld.2024.05.010_bib0001","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): a State-of-the-Art Review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"issue":"4","key":"10.1016\/j.dld.2024.05.010_bib0002","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"12","key":"10.1016\/j.dld.2024.05.010_bib0003","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.dld.2024.05.010_bib0004","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study","volume":"5","author":"Global Burden of Disease Cancer","year":"2019","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.dld.2024.05.010_bib0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/hep.32542","article-title":"NAFLD-related hepatocellular carcinoma: the growing challenge","volume":"77","author":"Shah","year":"2023","journal-title":"Hepatol (Baltimore, Md)"},{"issue":"4","key":"10.1016\/j.dld.2024.05.010_bib0006","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2024.05.010_bib0007","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"4","key":"10.1016\/j.dld.2024.05.010_bib0008","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11892-017-0851-x","article-title":"Type 2 Diabetes and hepatocellular carcinoma: risk factors and pathogenesis","volume":"17","author":"Wainwright","year":"2017","journal-title":"Curr. Diab. Rep."},{"issue":"5","key":"10.1016\/j.dld.2024.05.010_bib0009","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1210\/en.2016-1582","article-title":"Liver NF-\u03baB-inducing kinase promotes liver steatosis and glucose counterregulation in male mice with obesity","volume":"158","author":"Liu","year":"2017","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.dld.2024.05.010_bib0010","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3390\/genes10120966","article-title":"Network modeling approaches and applications to unravelling non-alcoholic fatty liver disease","volume":"10","author":"Blencowe","year":"2019","journal-title":"Genes (Basel)"},{"issue":"7","key":"10.1016\/j.dld.2024.05.010_bib0011","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.dld.2024.05.010_bib0012","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/bioinformatics\/bty721","article-title":"ImaGEO: integrative gene expression meta-analysis from GEO database","volume":"35","author":"Toro-Dominguez","year":"2019","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.dld.2024.05.010_bib0013","doi-asserted-by":"crossref","first-page":"e8793","DOI":"10.15252\/msb.20188793","article-title":"Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease","volume":"15","author":"Niu","year":"2019","journal-title":"Mol Syst Biol"},{"issue":"10","key":"10.1016\/j.dld.2024.05.010_bib0014","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol hepatol"},{"issue":"5","key":"10.1016\/j.dld.2024.05.010_bib0015","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology (Baltimore, Md"},{"issue":"5","key":"10.1016\/j.dld.2024.05.010_bib0016","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.dld.2024.05.010_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/data5020038","article-title":"Bioinformatics analysis identifying key biomarkers in Bladder cancer","volume":"5","author":"Zhang","year":"2020","journal-title":"Data"},{"issue":"10","key":"10.1016\/j.dld.2024.05.010_bib0018","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1194\/jlr.M069807","article-title":"Cholesterol 7alpha-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis","volume":"57","author":"Liu","year":"2016","journal-title":"J Lipid Res"},{"issue":"8","key":"10.1016\/j.dld.2024.05.010_bib0019","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4254\/wjh.v9.i8.443","article-title":"Meta-analysis reveals up-regulation of cholesterol processes in non-alcoholic and down-regulation in alcoholic fatty liver disease","volume":"9","author":"Wruck","year":"2017","journal-title":"World J Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2024.05.010_bib0020","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab"},{"issue":"7","key":"10.1016\/j.dld.2024.05.010_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102056","article-title":"Selective PPARdelta agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathway","volume":"298","author":"Kouno","year":"2022","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.dld.2024.05.010_bib0022","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.114.301621","article-title":"PCSK9: a key modulator of cardiovascular health","volume":"114","author":"Seidah","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.dld.2024.05.010_bib0023","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.atherosclerosis.2018.09.008","article-title":"Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population","volume":"278","author":"Wargny","year":"2018","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.dld.2024.05.010_bib0024","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/07853890.2016.1188328","article-title":"Liver fat accumulation is associated with circulating PCSK9","volume":"48","author":"Ruscica","year":"2016","journal-title":"Ann. Med."},{"issue":"1","key":"10.1016\/j.dld.2024.05.010_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12944-021-01610-w","article-title":"NAFLD fibrosis score is correlated with PCSK9 and improves outcome prediction of PCSK9 in patients with chest pain: a cohort study","volume":"21","author":"Peng","year":"2022","journal-title":"Lipids Health Dis"},{"issue":"3","key":"10.1016\/j.dld.2024.05.010_bib0026","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.numecd.2020.11.009","article-title":"Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience","volume":"31","author":"Scicali","year":"2021","journal-title":"Nutrit, Metabol Cardiovascular Dis"},{"issue":"1","key":"10.1016\/j.dld.2024.05.010_bib0027","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12672-022-00521-1","article-title":"Acetyl-CoA synthetase 2(ACSS2): a review with a focus on metabolism and tumor development","volume":"13","author":"Ling","year":"2022","journal-title":"Discov Oncol"},{"issue":"6037","key":"10.1016\/j.dld.2024.05.010_bib0028","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"issue":"40","key":"10.1016\/j.dld.2024.05.010_bib0029","doi-asserted-by":"crossref","first-page":"E9499","DOI":"10.1073\/pnas.1806635115","article-title":"ACSS2 promotes systemic fat storage and utilization through selective regulation of genes involved in lipid metabolism","volume":"115","author":"Huang","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.dld.2024.05.010_bib0030","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1021\/acsmedchemlett.9b00295","article-title":"Inhibition of ACSS2 for Treatment of Cancer and Neuropsychiatric Diseases","volume":"10","author":"Kargbo","year":"2019","journal-title":"ACS Med Chem Lett"},{"issue":"11","key":"10.1016\/j.dld.2024.05.010_bib0031","doi-asserted-by":"crossref","DOI":"10.1097\/MEG.0b013e32832b77ae","article-title":"Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance","volume":"21","author":"Yilmaz","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.dld.2024.05.010_bib0032","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/liv.14554","article-title":"Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity","volume":"40","author":"Barchetta","year":"2020","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2024.05.010_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1248376","article-title":"Programmed cell death and lipid metabolism of macrophages in NAFLD","volume":"14","author":"Xiao","year":"2023","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.dld.2024.05.010_bib0034","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.dld.2024.05.010_bib0035","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/en.2015-1866","article-title":"Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-Fed mice","volume":"157","author":"Wilson","year":"2016","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.dld.2024.05.010_bib0036","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2018.04.006","article-title":"CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis","volume":"69","author":"Zhao","year":"2018","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.dld.2024.05.010_bib0037","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/ijms18020434","article-title":"Proteome characteristics of non-alcoholic steatohepatitis liver tissue and associated hepatocellular carcinomas","volume":"18","author":"Kakehashi","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.dld.2024.05.010_bib0038","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1053\/j.gastro.2010.07.057","article-title":"Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease","volume":"139","author":"Chalasani","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.dld.2024.05.010_bib0039","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1053\/j.gastro.2011.01.060","article-title":"Polymorphism in the farnesyl diphosphate farnesyl transferase 1 gene and nonalcoholic fatty liver disease severity","volume":"140","author":"Ballestri","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.010_bib0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12876-015-0382-3","article-title":"Western diet-induced hepatic steatosis and alterations in the liver transcriptome in adult Brown-Norway rats","volume":"15","author":"Roberts","year":"2015","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2024.05.010_bib0041","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41467-017-00566-9","article-title":"Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function","volume":"8","author":"Item","year":"2017","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.dld.2024.05.010_bib0042","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/nm1625","article-title":"Lack of Fas antagonism by Met in human fatty liver disease","volume":"13","author":"Zou","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.dld.2024.05.010_bib0043","article-title":"Predicting non-alcoholic fatty liver disease progression and immune deregulations by specific gene expression patterns","volume":"11","author":"Zeng","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.dld.2024.05.010_bib0044","doi-asserted-by":"crossref","first-page":"12361","DOI":"10.1038\/s41598-017-10930-w","article-title":"Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis","volume":"7","author":"Ryaboshapkina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2024.05.010_bib0045","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3389\/fendo.2019.00599","article-title":"Integrated analysis of multiple microarray studies to identify novel gene signatures in non-alcoholic fatty liver disease","volume":"10","author":"Jia","year":"2019","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824007679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824007679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:34:24Z","timestamp":1778621664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865824007679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1590865824007679"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2024.05.010","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of key markers for the stages of nonalcoholic fatty liver disease: An integrated bioinformatics analysis and experimental validation","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2024.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}